We are live on ! Find out more
BA

Bridgewater Advisors Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+22.9%
3 Year Est. Return
+61.02%
5 Year Est. Return
+71.76%
10 Year Est. Return
AUM
$119M
AUM Growth
+$20M
Cap. Flow
+$281M
Cap. Flow %
234.77%
Top 10 Hldgs %
40.12%
Holding
106
New
13
Increased
20
Reduced
31
Closed
8

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.93M
2
AGN
Allergan Inc
AGN
+$1.73M
3
BG icon
Bunge Global
BG
+$1.32M
4
SEB icon
Seaboard Corp
SEB
+$1.08M
5
C icon
Citigroup
C
+$275K

Sector Composition

Rank Sector Weight
1 Consumer Staples 12.66%
2 Energy 10.17%
3 Healthcare 7.51%
4 Technology 7.19%
5 Financials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
101
Citigroup
C
$227B
-5,779
Closed -$275K
GGB icon
102
Gerdau
GGB
$9.74B
-13,210
Closed -$67K
RH icon
103
RH
RH
$3.47B
-2,795
Closed -$206K
SEB icon
104
Seaboard Corp
SEB
$4.06B
-413
Closed -$1.08M
FRTX
105
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-3
Closed -$14K
AGN
106
DELISTED
Allergan Inc
AGN
-13,973
Closed -$1.73M

Similar funds

Bridgewater Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Bridgewater Advisors held 106 positions worth $119M, up 20% from $99.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Bridgewater Advisors deployed $281M of net new capital in Q2 2014, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.

By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, up from 12% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $1.93M trimmed.

  • Bridgewater Advisors's largest Q2 2014 buy was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
  • Bridgewater Advisors added most to Berkshire Hathaway Class A in Q2 2014, an estimated $266M increase.
  • Bridgewater Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.93M.
  • Bridgewater Advisors fully exited Allergan Inc in Q2 2014, selling an estimated $1.73M.
  • Bridgewater Advisors's ten largest holdings make up 40% of its $119M portfolio in Q2 2014.
  • Bridgewater Advisors opened 13 new positions and closed 8 in Q2 2014.
  • Bridgewater Advisors's portfolio value rose 20% quarter-over-quarter to $119M.

Based on Bridgewater Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.